These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18307288)

  • 1. Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
    Wilkinson BL; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2008 Mar; 51(6):1945-53. PubMed ID: 18307288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII.
    Meleddu R; Maccioni E; Distinto S; Bianco G; Melis C; Alcaro S; Cottiglia F; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3281-4. PubMed ID: 26073006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Sharma V; Angeli A; Kumar R; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Apr; 150():678-686. PubMed ID: 29571155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors.
    Vats L; Kumar R; Bua S; Nocentini A; Gratteri P; Supuran CT; Sharma PK
    Eur J Med Chem; 2019 Dec; 183():111698. PubMed ID: 31539777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Supuran CT; Poulsen SA
    J Med Chem; 2006 Nov; 49(22):6539-48. PubMed ID: 17064072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Sep; 45(9):3656-61. PubMed ID: 20554082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
    Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
    Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
    Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.